, Health and Social Care Committee
Motion under Standing Order 17.42(ix) to resolve to exclude the public for items 4, 5 and 8
We're going to come back into public session for our next panel on gynaecological cancers, at 11 o'clock, but I move to item 3 now. Under Standing Order 17.42, can I resolve that we exclude the public for items 4, 5 and 8, if Members are happy? Thank you…
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Thank you. If there are no other questions from Members, that draws this session to an end. But can I thank you, Professor Khaw, Sharon Hillier, for your evidence this morning and your detailed written evidence as well—very much appreciated. Thank you for the…
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Professor Khaw, do you want to come in?
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Helpful. Thank you.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Did you want to come back in here on the other point, Professor Khaw, as well?
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Gareth Davies.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
I'm sure you're never a headache, Jack. Gareth Davies.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Thank you, Sarah, and Sharon, thank you for agreeing to the additional written evidence as well; it's appreciated. Jack, you wanted to come in on a question.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Thank you. Sarah Murphy.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
No, that's fine. We'll come back to that. Sarah Murphy wants to come in on that, but I'm going to come to Joyce Watson first and then I'll come to Sarah. Joyce Watson.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Yes, that's helfpul.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Rhun, you wanted to come in.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Thank you. Jack Sargeant.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Thank you. Gareth, you want to come in briefly, then I'll come to Jack for his questions. Gareth.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Thank you. Rhun, you wanted to come in.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
And just to ask about any campaigning that you might think of running, in terms of ovarian cancer symptoms as well—.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Thank you. And I should thank you also, both, for your substantial written evidence, which is very helpful to us also. I notice in your evidence you said, 'It is very unlikely, based on the current available evidence', that a specific awareness raising…
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Lovely. Well, thank you ever so much, both, for being with us this morning. I know that, previously, Public Health Wales has supported NHS-led awareness campaigns for cancer symptoms. I just want to gauge from you how successful you think those campaigns have…
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
Thank you.
, Health and Social Care Committee
Gynaecological cancers: Panel 5 - Public Health Wales
So, I move to item 2. Item 2 is in regards to our—this is our fifth evidence session—inquiry on gynaecological cancers, and this morning we're hearing from representatives from Public Health Wales. So, I'd be very grateful if you could, first of all, just…
, Health and Social Care Committee
Introductions, apologies, substitutions and declarations of interest
Good morning and welcome to the Health and Social Care Committee this morning. First of all, just to say that, this morning, we're operating in a hybrid session. So, we've got one Member joining us virtually, and, as always, we're operating bilingually. There…
, Plenary
Statement by the Minister for Health and Social Services: Quality Statement for Diabetes
Can I thank the Minister for the statement today? I'm pleased that we have a quality statement for diabetes in Wales, because I think we need something for Government policy to orientate around a set of guidance or aims that will help focus policy makers in…
, Health and Social Care Committee
Group 12: Review of the impact and effectiveness of the Health Service Procurement (Wales) Act (Amendments 10, 12)
Can I thank, first of all, the Minister and her officials for their attendance today? And can I say thank you also, on behalf of the committee, for the great support we've had from the clerking team and the researchers and the legal team during the course of…
, Health and Social Care Committee
Group 12: Review of the impact and effectiveness of the Health Service Procurement (Wales) Act (Amendments 10, 12)
That completes Stage 2 proceedings in accordance with Standing Order 26.26. Stage 3 begins tomorrow. The relevant dates for Stage 3 proceedings will be published in due course, and Standing Orders make provision for the Member in charge to prepare a revised…
, Health and Social Care Committee
Group 12: Review of the impact and effectiveness of the Health Service Procurement (Wales) Act (Amendments 10, 12)
The question is that amendment 13 be agreed. Does any Member object? [Objection.] Therefore, we proceed to a vote. The question is that amendment 13 be agreed. Those in favour, please raise your hands. There are three in favour. Those against. There are three…
